浙江匯力藥業(yè)有限公司創(chuàng)建于1981年，專注藥用空心膠囊研發(fā)制造四十余年。公司現(xiàn)擁有5500平方米10萬級潔凈車間，配備18條智能化生產(chǎn)線，年產(chǎn)膠囊100億粒，產(chǎn)品涵蓋明膠膠囊、植物膠囊、無二氧化鈦膠囊及無環(huán)氧乙烷滅菌膠囊四大系列，通過歐盟GMP等國際認(rèn)證。2023年，集團(tuán)旗下浙江匯力膠囊有限公司在杭州經(jīng)濟(jì)技術(shù)開發(fā)區(qū)啟動總投資8億元的智能植物膠囊基地項目，打造覆蓋全球區(qū)域的現(xiàn)代化植物膠囊生產(chǎn)中心及大健康產(chǎn)品一體化OEM服務(wù)平臺。企業(yè)依托自主創(chuàng)新研發(fā)體系，將綠色生產(chǎn)工藝與智能化生產(chǎn)深度融合，為全球客戶提供創(chuàng)新型解決方案。

   Zhejiang Huili Pharmaceutical Co., Ltd., established in 1981, has specialized in the R&D and manufacturing of pharmaceutical hollow capsules for over four decades. The company operates a 5,500-square-meter 100,000-class clean workshop equipped with 18 intelligent production lines, achieving an annual production capacity of 10 billion capsules. Its product portfolio spans four major series: gelatin capsules, plant-based capsules, titanium dioxide-free capsules, and ethylene oxide-free sterilized capsules, all certified under international standards including EU GMP.

   In 2023, its subsidiary Zhejiang Huili Capsule Co., Ltd. launched an RMB 800 million intelligent plant-based capsule production base project in Hangzhou Economic and Technological Development Zone, aiming to build a world-leading modern plant-based capsule manufacturing hub and an integrated OEM service platform for comprehensive health products.

   By leveraging its independent R&D system, the company seamlessly integrates green production processes with intelligent manufacturing to provide innovative solutions for global clients. This initiative reinforces its commitment to advancing pharmaceutical excipients and health product innovation while driving sustainable industrial transformation.